stockrowCharles River Laboratories International, Inc. (CRL) vs Quest Diagnostics Incorporated (DGX)
- Charles River Laboratories International, Inc. CRL 313.98 −3.77%
- Quest Diagnostics Incorporated DGX 254.25 −0.56%
Charles River Laboratories International, Inc. and Quest Diagnostics Incorporated are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $28.0B against $14.9B — 1.9× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 300×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.13% against −1.16%. Quest Diagnostics Incorporated has the higher net margin (9.50% vs 1.01%) and the higher return on invested capital (8.48% vs 1.81%). Across the 22 metrics below, Quest Diagnostics Incorporated leads on 19 and Charles River Laboratories International, Inc. on 3.
Valuation
Profitability
| Metric | CRL | DGX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.33% | 33.11% | 48.32% |
| Operating margin | 4.00% | 14.55% | (5.68%) |
| Net margin | 1.01% | 9.50% | (4.10%) |
| Free cash flow margin | 10.05% | 11.61% | 0.00% |
| Return on equity | 1.21% | 14.76% | 0.00% |
| Return on assets | 0.54% | 6.73% | (6.05%) |
| Return on invested capital | 1.81% | 8.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack